NCT02544256

Brief Summary

The purpose of this study is to determine whether mild hypothermia causes reduction of vasoconstriction in microcirculation after clipping of aneurysms, and affects the blood flow in small diameter arteries at operating site (ischemia-hyperemia) and occurrence of vasospasms during the period of 14 postoperative days measured by transcranial Doppler.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 9, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

October 18, 2016

Status Verified

October 1, 2016

Enrollment Period

2.8 years

First QC Date

August 27, 2015

Last Update Submit

October 17, 2016

Conditions

Keywords

MicrocirculationMild Hypothermia, InducedSubarachnoid Hemorrhage, AneurysmalAneurysmal ClippingVasospasms

Outcome Measures

Primary Outcomes (1)

  • Changes in Sidestream Dark Field (SDF) imaging variables

    brain microcirculation will be measured by sidestream-dark field imaging (SDF) probe

    1 and 2 hours after skin incision

Secondary Outcomes (2)

  • Changes in diameter of small brain arteries at operating site

    1 and 2 hours after skin incision

  • Occurrence of vasospasms

    within the first 14 days after surgery

Other Outcomes (2)

  • Days of hospital stay

    participants will be followed for the duration of hospital stay, an expected average of 3 weeks

  • Glasgow outcome score (GOS) on discharge

    2 weeks after operation

Study Arms (2)

Mild hypothermia

EXPERIMENTAL

After induction to general anaesthesia the patients will be cooled to 33° C. Targeted body temperature 33,8° C - 34,8° will be maintained up to the end of microcirculation measurement after aneurysm clipping.

Procedure: Mild hypothermia

Normothermia

NO INTERVENTION

The body temperature will be maintained in the range 35,8° C - 36,8° C.

Interventions

Mild hypothermia during surgical clipping of brain aneurysm will be reached by cooling to body temperature 33,8° C - 34,8° and this temperature maintained up to the end of microcirculation measurement after aneurysm clipping.

Mild hypothermia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute subarachnoidal hemorrhage based on ruptured aneurysm
  • Hunt and Hess scale 1-4
  • Clipping up to 72 hours after the rupture

You may not qualify if:

  • Known cryoglobulinemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Hradec Kralove

Hradec Králové, 50005, Czechia

Location

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Interventions

Hypothermia, Induced

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CryotherapyTherapeutics

Study Officials

  • Vlasta Dostalova, MD, PhD

    University Hospital Hradec Kralove

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dostalova Vlasta, MD, PhD

Study Record Dates

First Submitted

August 27, 2015

First Posted

September 9, 2015

Study Start

December 1, 2015

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

October 18, 2016

Record last verified: 2016-10

Locations